Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07398456
What this trial is testing

Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas

Who this might be right for
Colorectal Cancer (CRC) Screening
Baylor Research Institute 5,500
Not applicableStudy completedNCT07403370
What this trial is testing

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Who this might be right for
Solid TumoursOlanzapineNausea and Vomiting
Shandong Cancer Hospital and Institute 2,493
Testing effectiveness (Phase 2)Looking for participantsNCT06488222
What this trial is testing

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Who this might be right for
Bladder Cancer
University of Florida 34
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Not applicableEnrolling By InvitationNCT07234539
What this trial is testing

Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management

Who this might be right for
Thyroid CancerLarge Language Models
The University of Hong Kong 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Not applicableActive Not RecruitingNCT03990610
What this trial is testing

An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Not applicableStudy completedNCT05300789
What this trial is testing

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Who this might be right for
Peritoneal CarcinomatosisColon Cancer
Carlos Cerdán Santacruz 1,152
Not applicableStudy completedNCT01293617
What this trial is testing

Blackberry Intake and Biomarkers of Cancer Risk

Who this might be right for
Healthy Volunteers
United States Department of Agriculture (USDA) 52
Testing effectiveness (Phase 2)Study completedNCT00794950
What this trial is testing

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract Urothelial Carcinoma
University of Michigan 43
Testing effectiveness (Phase 2)Study completedNCT01530997
What this trial is testing

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 45
Not applicableStudy completedNCT03225222
What this trial is testing

MRI in PROstate Cancer Diagnosis With Prior Risk Assessment

Who this might be right for
Prostate Cancer
Erasmus Medical Center 2,558
Not applicableStudy completedNCT04543851
What this trial is testing

CARA Treatment Pilot Study for Breast Positioning

Who this might be right for
Breast CancerSide Effect
British Columbia Cancer Agency 20
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Testing effectiveness (Phase 2)Study completedNCT00276692
What this trial is testing

Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Cancer and Leukaemia Group 35
Not applicableLooking for participantsNCT06146764
What this trial is testing

CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Who this might be right for
Thyroid NoduleThyroid Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232
What this trial is testing

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 90
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Next Page